Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Epstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a protein.

Kashuba E, Yurchenko M, Szirak K, Stahl J, Klein G, Szekely L.

Exp Cell Res. 2005 Feb 1;303(1):47-55.

PMID:
15572026
2.
3.

Epstein-Barr virus encoded nuclear protein EBNA-3 binds a novel human uridine kinase/uracil phosphoribosyltransferase.

Kashuba E, Kashuba V, Sandalova T, Klein G, Szekely L.

BMC Cell Biol. 2002 Aug 29;3:23. Epub 2002 Aug 29.

5.

Epstein-Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen.

Kashuba E, Kashuba V, Pokrovskaja K, Klein G, Szekely L.

Oncogene. 2000 Mar 30;19(14):1801-6.

6.

Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.

McClain K, Estrov Z, Raju U, Kelley PK, Aggarwal BB.

Methods. 1997 Jan;11(1):83-7.

PMID:
8990093
8.

P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.

Wang Y, Finan JE, Middeldorp JM, Hayward SD.

Virology. 1997 Sep 15;236(1):18-29.

9.
10.

Epstein-barr virus nuclear antigen-1 binds to nuclear transporter karyopherin alpha1/NPI-1 in addition to karyopherin alpha2/Rch1.

Ito S, Ikeda M, Kato N, Matsumoto A, Ishikawa Y, Kumakubo S, Yanagi K.

Virology. 2000 Jan 5;266(1):110-9.

11.

PRIMA-1MET induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein.

Stuber G, Flaberg E, Petranyi G, Otvös R, Rökaeus N, Kashuba E, Wiman KG, Klein G, Szekely L.

Mol Cancer. 2009 Mar 26;8:23. doi: 10.1186/1476-4598-8-23.

13.
14.

Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes.

Hertle ML, Popp C, Petermann S, Maier S, Kremmer E, Lang R, Mages J, Kempkes B.

PLoS Pathog. 2009 Jul;5(7):e1000506. doi: 10.1371/journal.ppat.1000506. Epub 2009 Jul 3.

15.

Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.

Yalamanchili R, Tong X, Grossman S, Johannsen E, Mosialos G, Kieff E.

Virology. 1994 Nov 1;204(2):634-41.

PMID:
7941331
17.

Epstein-Barr nuclear antigen-3 and -4 interact with RBP-2N, a major isoform of RBP-J kappa in B lymphocytes.

Krauer KG, Kienzle N, Young DB, Sculley TB.

Virology. 1996 Dec 15;226(2):346-53.

18.

Resting B-cells, EBV-infected B-blasts and established lymphoblastoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns.

Szekely L, Pokrovskaja K, Jiang WQ, Selivanova G, Löwbeer M, Ringertz N, Wiman KG, Klein G.

Oncogene. 1995 May 4;10(9):1869-74.

PMID:
7753563
19.

Regulation of transcription by the Epstein-Barr virus nuclear antigen EBNA 2.

Palermo RD, Webb HM, Gunnell A, West MJ.

Biochem Soc Trans. 2008 Aug;36(Pt 4):625-8. doi: 10.1042/BST0360625.

PMID:
18631129
20.

Supplemental Content

Support Center